# US 2025/0144155 A1 · Topical composition comprised of cod liver oil for treating wounds and skin disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0144155 A1
- Document ID: US20250144155A1
- Status: Published application
- Kind: A1
- Application number: 19/008,740
- Filed: 2025-01-03
- Published: 2025-05-08
- Earliest claimed: 2018-04-13
- Assignees: Omeza Holdings, Inc.
- Applicants: Omeza Holdings, Inc.
- Inventors: Griscom Bettle, III; John Harlin; Thomas Gardner
- Web page: https://patentgrep.com/patent/US20250144155A1

## CPC

- A61K 35/60: Fish, e.g. seahorses; Fish eggs
- A61K 8/361: {Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof}
- A61K 8/37: Esters of carboxylic acids
- A61K 8/65: Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
- A61K 8/922: {of vegetable origin}
- A61K 8/925: {of animal origin}
- A61K 8/965: {of inanimate origin}
- A61K 8/97: from algae, fungi, lichens or plants; from derivatives thereof
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 31/14: Quaternary ammonium compounds, e.g. edrophonium, choline (betaines A61K31/205)
- A61K 31/167: having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A61K 31/20: having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K 31/23: of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K 35/644: Beeswax; Propolis; Royal jelly; Honey
- A61K 36/3482: {Cannabis}
- A61K 36/889: Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
- A61K 47/14: Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A61K 47/22: Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A61K 47/38: Cellulose; Derivatives thereof
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61Q 19/00: Preparations for care of the skin
- A61Q 19/005: {Preparations for sensitive skin}
- A61Q 19/007: {Preparations for dry skin}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Described herein relates to a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.

## Claims

### Claim 1

A method for synthesizing an anhydrous topical composition comprising an omega fatty acid product, the method comprising:
subjecting a mixture to a heating vessel and a cooling vessel to yield a homogenous oil product;
using the homogenous oil product, a derivative thereof, or both to form the anhydrous topical composition comprising the omega fatty acid product, wherein the omega fatty acid product comprises (i) about 5% to about 30% cod liver oil by weight; (ii) about 10% to about 30% hempseed oil by weight; (iii) about 2% to about 8% thickening agent by weight; (iv) about 0.3% to about 0.6% ascorbyl palmitate by weight; and (v) a fish collagen;
wherein the ascorbyl palmitate is sterically hindered from entering the fish collagen, whereby the ascorbyl palmitate precipitates on an outer surface of the fish collagen; and
wherein subsequent to the thickening agent and the ascorbyl palmitate being incorporated within the omega fatty acid product, the combination of the thickening agent and ascorbyl palmitate inhibits the cod liver oil, the hempseed oil, or both from seeping from the fish collagen.

### Claim 2 (depends on 1)

The method of claim 1, wherein the step of subjecting the mixture to a heating vessel and a cooling vessel further comprises the step of, incorporating the fish collagen at a temperature of at least 130° F., wherein the fish collagen comprises a plurality of pores.

### Claim 3 (depends on 2)

The method of claim 2, wherein the cod liver oil, the hempseed oil, or both are configured to fill each of the plurality of pores of the fish collagen.

### Claim 4 (depends on 3)

The method of claim 3, wherein the step of subjecting the mixture to a heating vessel and a cooling vessel further comprises the step of, when the cod liver oil, the hempseed oil, or both fill each of the plurality of pores of the fish collagen, cooling the mixture to room temperature.

### Claim 5 (depends on 4)

The method of claim 4, wherein the hempseed oil and the cod liver oil are present in a weight ratio of the hempseed oil to the cod liver oil ranging from about 1.5:1 to about 1:1.

### Claim 6 (depends on 5)

The method of claim 5, wherein the step of subjecting the mixture to a heating vessel and a cooling vessel further comprises the step of, incorporating a thickening agent to the mixture at a temperature of at least 130° F.

### Claim 7 (depends on 6)

The method of claim 6, wherein the omega fatty acid product comprises at least 20% medium chain triglycerides (hereinafter “MCT”) by weight.

### Claim 8 (depends on 1)

The method of claim 1, wherein the omega fatty acid product is configured to reduce swelling.

### Claim 9 (depends on 8)

The method of claim 8, wherein the omega fatty acid product inhibits pain when applied to the wound.

### Claim 10

A method for synthesizing an anhydrous topical composition, the method comprising:
blending cod liver oil, hempseed oil, and medium-chain triglycerides (MCTs) into a mixture within an inert atmosphere at a temperature between about 40° C. and about 80° C., thereby ensuring homogeneity;
incorporating ascorbyl palmitate into the blended mixture;
introducing a fish collagen into the blended mixture while maintaining the temperature between about 40° C. and about 80° C., thereby ensuring uniform penetration of the cod liver oil, the hempseed oil, or both into a plurality of pores of the fish collagen;
adjusting the temperature, the inert atmosphere, or both until the blended mixture forms a hard, ambient solid product; and
whipping the product under an additional inert gas to achieve a viscosity suitable for extrusion from a packaging.

### Claim 11 (depends on 10)

The method of claim 10, wherein the inert gas, the additional inert gas, or both comprise nitrogen, argon, or both.

### Claim 12 (depends on 10)

The method of claim 10, wherein the blended mixture further comprises a thickening agent.

### Claim 13 (depends on 12)

The method of claim 12, wherein the thickening agent is beeswax, carnauba wax, and a combination of thereof.

### Claim 14 (depends on 13)

The method of claim 13, wherein the thickening agent is present in an amount ranging from about 2 wt % to about 6 wt % of the blended mixture.

### Claim 15 (depends on 10)

The method of claim 10, wherein the whipped product comprises a specific gravity between about 0.78 and about 0.81.

### Claim 16 (depends on 10)

The method of claim 10, wherein the whipped product comprises a weight ratio of total MCTs to fish collagen of about 1:1 and exhibits dual melting points separated by at least 13° C.

### Claim 17

A method for treating a skin condition, the method comprising:
applying a therapeutically effective dose of a topical composition to the skin condition, a surrounding periwound, or both the topical composition comprising:
about 5% to about 30% cod liver oil by weight;
about 10% to about 30% hempseed oil by weight;
about 2% to about 8% thickening agent by weight;
about 0.3% to about 0.6% ascorbyl palmitate by weight; and
a fish collagen;
wherein the ascorbyl palmitate is sterically hindered from entering the fish collagen, whereby the ascorbyl palmitate precipitates on an outer surface of the fish collagen; and
wherein subsequent to the thickening agent and the ascorbyl palmitate being incorporated within the omega fatty acid product, the combination of the thickening agent and ascorbyl palmitate inhibits the cod liver oil, the hempseed oil, or both from seeping from the fish collagen.

### Claim 18 (depends on 17)

The method of claim 17, wherein the step of applying a therapeutically effective dose of a topical composition to the skin condition, a surrounding periwound, or both further comprises the step of, evenly extruding the topical composition into a wound bed surface of the skin condition, the surrounding periwound, or both, thereby ensuring complete coverage of the topical composition.

### Claim 19 (depends on 18)

The method of claim 18, wherein the topical composition is configured to conform to the contours of the skin condition, the surrounding periwound, or both at body temperature.

### Claim 20 (depends on 19)

The method of claim 19, further comprising the step of, removing the originally applied topical composition and applying an additional therapeutically effective dose of the topical composition, thereby ensuring continued therapeutic efficacy and preventing desiccation of the wound bed of the skin condition, the surrounding periwound or both.
